These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1826344)

  • 41. Perioperative infection prophylaxis in colon surgery.
    Wohlfahrt R; Siedek M
    Chemioterapia; 1987 Jun; 6(2 Suppl):603-4. PubMed ID: 3334643
    [No Abstract]   [Full Text] [Related]  

  • 42. [Single-dose ceftriaxone versus multiple-dose cefuroxime for prophylaxis of surgical site infection].
    Li ZL; Tong SX; Yu BM; Tang WS; Wu ZY; Wang SB; Wu YF; Lu WQ; Luo M; Wang J
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):372-4. PubMed ID: 12892594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Perioperative antibiotic prophylaxis. A comparative study of 244 patients with colonic diseases].
    Eckert P; Brom A; Schneider G
    Wien Med Wochenschr Suppl; 1985; 87():21-7. PubMed ID: 3856972
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibiotic prophylaxis in high-risk biliary operations: multicenter trial of single preoperative ceftriaxone versus multidose cefazolin.
    Kellum JM; Gargano S; Gorbach SL; Talcof C; Curtis LE; Weiner B; McCoobery M; Tan JS; Kelly T; Wagner D
    Am J Surg; 1984 Oct; 148(4A):15-8. PubMed ID: 6091474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of a combination of ceftriaxone (Rocephin) and ornidazole (Tiberal) in the treatment of severe intra-abdominal infections in surgery].
    Vyhnánek F; Lochmannn O; Procházka M; Absolonová V
    Cesk Epidemiol Mikrobiol Imunol; 1986 Sep; 35(5):299-306. PubMed ID: 2944632
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antibiotic prophylaxis before kidney transplantation].
    Robles NR; Gallego E; Anaya F; Franco A; Valderrábano F
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):74-7. PubMed ID: 2098143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities.
    Alekwe LO; Kuti O; Orji EO; Ogunniyi SO
    J Matern Fetal Neonatal Med; 2008 Sep; 21(9):638-42. PubMed ID: 18828055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Perioperative antibiotic prophylaxis in transperitoneal tumor nephrectomy: does it lower the rate of clinically significant postoperative infections?].
    Steiner T; Traue C; Schubert J
    Urologe A; 2003 Jan; 42(1):34-7. PubMed ID: 12574881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ceftriaxone vs. cefazolin in obstetrical surgical prevention].
    Figueroa Damián R; Ortíz Ibarra FJ; Labastida Domínguez VM; Villagrana Zesati R; García Benítez CQ; Arredondo García JL
    Ginecol Obstet Mex; 1995 Jul; 63():302-7. PubMed ID: 7665117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia (Br J Surg 2006; 93: 5-10).
    Nash GF
    Br J Surg; 2006 Jul; 93(7):891-2; author reply 892. PubMed ID: 16775827
    [No Abstract]   [Full Text] [Related]  

  • 51. Ceftriaxone for surgical prophylaxis: clinical experience and pharmacoeconomics.
    Periti P
    J Chemother; 2000 Sep; 12 Suppl 3():2-4. PubMed ID: 11432678
    [No Abstract]   [Full Text] [Related]  

  • 52. Meta-analysis of hyperoxia to prevent surgical site infection.
    Meyhoff CS; Jorgensen LN; Rasmussen LS; Wetterslev J
    J Am Coll Surg; 2011 May; 212(5):909; author reply 909-10. PubMed ID: 21530851
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of two cephalosporins in the surgical treatment of peritrochanteric fractures.
    Jones RN
    Chemotherapy; 1992; 38(3):197-200. PubMed ID: 1511636
    [No Abstract]   [Full Text] [Related]  

  • 54. Does a well-done analysis of poor-quality data constitute evidence of benefit?
    Barie PS
    Ann Surg; 2012 Jun; 255(6):1030-1. PubMed ID: 22549753
    [No Abstract]   [Full Text] [Related]  

  • 55. Worldwide clinical experience with ceftriaxone.
    Hell K
    Chemotherapy; 1989; 35(3):228-35. PubMed ID: 2766863
    [No Abstract]   [Full Text] [Related]  

  • 56. Evidence Corner: Controversy Surrounding Wound-edge Protectors.
    Bolton L
    Wounds; 2016 Aug; 28(8):295-7. PubMed ID: 27560473
    [No Abstract]   [Full Text] [Related]  

  • 57. Explaining the forest plot in meta-analyses.
    Stephenson J
    J Wound Care; 2017 Nov; 26(11):611-612. PubMed ID: 29131757
    [No Abstract]   [Full Text] [Related]  

  • 58. Ceftriaxone and wound infections meta-analysis.
    Burton ID
    N Z Med J; 1991 Mar; 104(908):126. PubMed ID: 1826344
    [No Abstract]   [Full Text] [Related]  

  • 59. Ceftriaxone and wound infections meta-analysis.
    Villiger J
    N Z Med J; 1991 Jun; 104(913):237. PubMed ID: 2052237
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of surgical wound infections (S.W.I.). Ten years of experience.
    Germiniani R; Longoni F; Semeraro GC
    Panminerva Med; 1987; 29(4):279-82. PubMed ID: 3324018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.